Intradermal Rabies Immunization Using NanoJect: A Comparative Study

NCT02538185 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Intradermal (ID) Vaccination Device

Interventions

DEVICE: NanoJect device (DebioJect™)
DEVICE: Classical syringe (1mL Becton Dickinson (BD) Luer-Lock™) with a 25 Guage (G) needle (Terumo® Neolus)
DEVICE: Classical syringe (1mL BD Luer-Lock™) with a 22G needle (Terumo® Neolus)
DRUG: Vaccin rabique Pasteur®
DRUG: Placebo

Sponsor

University of Lausanne Hospitals